STALICLA Awarded EUR 1.7 Million to Lead Computational Drug

STALICLA will be a leading contributor to the Euro-Global Platform for Mechanism-based Drug Repurposing (REPO4EU) consortium, with a EUR 1.7 million budget allocated to STALICLA Discovery and Data

Related Keywords

Kostenloser Wertpapierhandel , , Euro Global Platform , Mechanism Based Drug Repurposing , Data Science , Key Strategic Orientation , Horizon Europe , Strategic Plan , Neurodevelopmental Disorders , Autism Spectrum Disorder , Stalicla , Warded , Billion , Head , Computational , Drug , Repositioning , Activities , Funded , Epo4eu , Project ,